- Resource Centre
- Library for health research reporting
- Reporting Guidelines
- Experimental studies
- Observational studies
- Diagnostic accuracy studies
- Biospecimen reporting
- Reliability and agreement studies
- Systematic reviews and meta-analysis
- Qualitative research
- Mixed methods studies
- Economic evaluations
- Quality improvement studies
- Other reporting guidelines
- Reporting data
- Statistical methods and analyses
- Sections of research reports
- Specific conditions or procedures
- Reporting guidelines under development
- Reporting guidelines in other research fields
- Guidance on scientific writing
- Guidance developed by editorial groups
- Industry sponsored research - additional guidance
- Research ethics, publication ethics and good practice guidelines
- Development and maintenance of reporting guidelines
- Editorials introducing RGs
- Examples of guidelines for peer reviewers
- Case studies: RG implementation
- Examples of good research reporting
- Presentations
- EQUATOR 'pick'
- Reporting Guidelines
- Authors of research reports
- Editors and peer reviewers
- Reporting guidelines developers
- Promote responsible reporting
- Monitoring use of our resources
- Links
Guidelines for reporting economic evaluations
| Reporting guidance provided for: | Name of guideline website (where available) | References including PMID |
|---|---|---|
| Cost-effectiveness analyses | Siegel JE, Weinstein MC, Russell LB, Gold MR. Recommendations for
reporting cost-effectiveness analyses. Panel on Cost-Effectiveness in
Health and Medicine. JAMA 1996; 276(16):1339-1341. PMID: 8861994 |
|
| Cost-effectiveness analyses conducted as part of clinical trials (design, conduct, reporting) | ISPOR RCT-CEA | Ramsey S, Willke R, Briggs A, Brown R, Buxton M, Chawla A, Cook J,
Glick H, Liljas B, Petitti D, Reed S. Good Research Practices for
Cost-Effectiveness Analysis Alongside Clinical Trials: The ISPOR
RCT-CEA Task Force Report. Value in Health 2005; 8(5):521-533. PMID: 16176491 |
| Economic evaluation for trial-based studies and decision analytic models (design, analysis, reporting) | Drummond M, Manca A, Sculpher M. Increasing the generalizability of economic evaluations: recommendations for the design, analysis, and reporting of studies. Int J Technol Assess Health Care 2005; 21(2):165-171. PMID: 15921055 | |
| Economic evaluation (modelling studies) | Nuijten MJ, Pronk MH, Brorens MJ, Hekster YA, Lockefeer JH, de Smet PA, Bonsel G, van der Kuy A. Reporting format for economic evaluation. Part II: Focus on modelling studies. Pharmacoeconomics 1998; 14(3):259-268. PMID: 10186465 | |
| Economic evaluation |
|
Petrou S, Gray A. Economic evaluation alongside randomised controlled trials: design, conduct, analysis, and reporting. BMJ. 2011 7;342:d1548. doi: 10.1136/bmj.d1548. PMID: 21474510 |
| Economic evaluation (modelling) |
|
Petrou S, Gray A. Economic evaluation using decision analytical modelling: design, conduct, analysis, and reporting. BMJ. 2011 11;342:d1766. doi: 10.1136/bmj.d1766. PMID: 21482590 |
| Economic evaluation studies in obstetrics (design, execution, interpretation, reporting) | Vintzileos AM, Beazoglou T. Design, execution, interpretation, and
reporting of economic evaluation studies in obstetrics. Am J Obstet
Gynecol 2004; 191(4):1070-1076. PMID: 15507923 |
|
|
Economic evaluation of haemophilia prophylaxis |
Nicholson A, Berger K, Bohn R, Carcao M, Fischer K, Gringeri A, et al. Recommendations for reporting economic evaluations of haemophilia prophylaxis: a nominal groups consensus statement on behalf of the Economics Expert Working Group of The International Prophylaxis Study Group. Haemophilia 2008;14(1):127-32. PMID: 18005148 |
|
| Economic evaluations of fall prevention strategies |
|
Davis JC, Robertson MC, Comans T, Scuffham PA. Guidelines for conducting and reporting economic evaluation of fall prevention strategies. Osteoporos Int. 2011; 22(9):2449-59. PMID: 21104231 |
Page last edited: 20 October 2011
